Cargando…
Show Me the Money: Patients’ Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost
Out-of-pocket medication costs for patients who have heart failure with reduced ejection fraction may be an important part of shared decision-making, but cost has generally been excluded from clinical discussions. This study reports patients’ perspectives on a decision aid for sacubitril/valsartan t...
Autores principales: | Dickert, Neal W., Mitchell, Andrea R., Venechuk, Grace E., Matlock, Daniel D., Moore, Miranda A., Morris, Alanna A., Pierce, Kenneth J., Speight, Candace D., Allen, Larry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738420/ https://www.ncbi.nlm.nih.gov/pubmed/33302715 http://dx.doi.org/10.1161/CIRCOUTCOMES.120.007070 |
Ejemplares similares
-
Discussing Out‐of‐Pocket Costs With Patients: Shared Decision Making for Sacubitril‐Valsartan in Heart Failure
por: Smith, Graham H., et al.
Publicado: (2018) -
PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19
por: Thomson, Mary Catherine, et al.
Publicado: (2021) -
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure
por: Rao, Birju R., et al.
Publicado: (2022) -
Framing Benefits in Decision Aids: Effects of Varying Contextualizing
Statements on Decisions About Sacubitril-Valsartan for Heart
Failure
por: Thomson, Mary C., et al.
Publicado: (2021) -
Deciding Whether to Take Sacubitril/Valsartan: How Cardiologists and Patients Discuss Out‐of‐Pocket Costs
por: Rao, Birju R., et al.
Publicado: (2023)